We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
(+31%)
Cap. Flow
+$324M
Cap. Flow
% of AUM
2.32%
Top 10 Holdings %
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$176M |
| 2 |
Infosys
INFY
|
+$102M |
| 3 |
K
Kellanova
K
|
+$74.6M |
| 4 |
Amazon
AMZN
|
+$58.6M |
| 5 |
Alibaba
BABA
|
+$52.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$114M |
| 2 |
HDFC Bank
HDB
|
+$97.7M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$55.3M |
| 4 |
Roper Technologies
ROP
|
+$45.7M |
| 5 |
Nutanix
NTNX
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.38% |
| 2 | Financials | 4.13% |
| 3 | Consumer Discretionary | 2.33% |
| 4 | Communication Services | 2.26% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVCC
276
Stellar V Capital Corp
SVCC
$230M
| $8.69M | 0.06% |
850,000
| – | – |
|
|
NVO
277
PUT
Novo Nordisk
NVO
$216B
| $8.63M | 0.06% |
125,100
+115,100
| +1,151% | +$7.83M |
|
|
COPL.U
278
Copley Acquisition Corp Units
COPL.U
| $8.59M | 0.06% |
+850,000
| New | +$8.55M |
|
|
279
PUT
Alibaba
BABA
$269B
| $8.51M | 0.06% |
75,000
-24,000
| -24% | -$2.84M |
|
280
Carvana
CVNA
$43.3B
| $8.38M | 0.06% |
124,350
-598,150
| -83% | -$32.8M |
|
281
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
| $8.29M | 0.06% |
+100,000
| New | +$8.12M |
|
|
RAC.U
282
Rithm Acquisition Corp Units
RAC.U
| $8.29M | 0.06% |
800,000
| – | – |
|
|
ANSS
283
DELISTED
Ansys
ANSS
| $8.27M | 0.06% |
23,551
-84,549
| -78% | -$27.7M |
|
284
Super Micro Computer
SMCI
$19.5B
| $8.27M | 0.06% |
+168,705
| New | +$6.5M |
|
285
Joby Aviation Warrants
JOBY.WS
| $8.25M | 0.06% |
3,436,889
+65,300
| +2% | +$88.1K |
|
286
Hims & Hers Health
HIMS
$6.5B
| $8.22M | 0.06% |
164,855
+164,838
| +969,635% | +$7.45M |
|
|
TDAC
287
Translational Development Acquisition Corp
TDAC
$207M
| $8.22M | 0.06% |
800,000
| – | – |
|
288
CALL
Novartis
NVS
$295B
| $8.16M | 0.06% |
67,400
+18,700
| +38% | +$2.11M |
|
289
Vodafone
VOD
$34.9B
| $8.13M | 0.06% |
762,659
| – | – |
|
290
Match Group
MTCH
$8.84B
| $8.13M | 0.06% |
263,171
+125,753
| +92% | +$3.76M |
|
291
Pegasystems
PEGA
$4.41B
| $8.12M | 0.06% |
+150,000
| New | +$6.8M |
|
292
CALL
Truist Financial
TFC
$63.2B
| $8.08M | 0.06% |
187,900
+12,400
| +7% | +$485K |
|
|
XRPN
293
Armada Acquisition Corp II
XRPN
$331M
| $8.04M | 0.06% |
+800,000
| New | +$8.03M |
|
294
AB InBev
BUD
$158B
| $7.97M | 0.06% |
+116,000
| New | +$7.79M |
|
|
LKFT
295
CALL
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
| $7.93M | 0.06% |
+283,400
| New | +$7.6M |
|
296
Fortinet
FTNT
$112B
| $7.93M | 0.06% |
75,000
+45,000
| +150% | +$4.54M |
|
|
SARO
297
StandardAero Inc
SARO
$9.54B
| $7.91M | 0.06% |
250,000
| – | – |
|
|
298
PUT
AB InBev
BUD
$158B
| $7.89M | 0.06% |
114,800
+42,700
| +59% | +$2.87M |
|
299
PUT
Applied Materials
AMAT
$426B
| $7.84M | 0.06% |
42,800
-9,700
| -18% | -$1.54M |
|
|
VCIC
300
DELISTED
Vine Hill Capital Investment Corp
VCIC
| $7.8M | 0.06% |
750,310
| – | – |
|
Similar funds
AS
TI
LMR Partners's Q2 2025 Portfolio in Review
As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
- LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
- LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
- LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
- LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
- LMR Partners opened 418 new positions and closed 391 in Q2 2025.
- LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.
Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.